Join Dr. Shaw for an explanation of The Great Plains Laboratory’s Organic Acids Test (OAT) from the creator himself. GPL’s most popular test was recently expanded to 74 markers and their OAT is U.S. Patented, offering twice the number of markers than their competitors. Dr. Shaw will explain this unique test in detail and review the results of five OAT cases.
The OAT provides a metabolic “snapshot” based on the products the body discards through the urine. These small, discarded organic acid molecules are byproducts of human cellular activity, the digestion of foods, and the metabolism of gastrointestinal flora. At certain levels, organic acids in urine may be indicators of toxicity or “markers” of the function of metabolic pathways. Levels of yeast or gastrointestinal bacteria metabolites are compared to normal levels of human metabolites, providing an assessment of yeast and bacterial activity.
The new and improved OAT has increased the number of tested compounds to 74 and two new ratios have been added. The new compounds detected may result from variations in vitamin and hormone metabolism, energy level, intestinal wall integrity, neurotransmission, and muscle function.
Many new technologies have revealed significant new factors as causes of autistic spectrum disorders including genomics, proteomics, and metabolomics, disciplines involved in mass screening of genes, proteins, and metabolic processes in humans. These technologies have already lead to significant new therapeutic trials for autistic spectrum disorders. In addition, a number of recent studies have implicated both environmental factors and genetic factors related to detoxification as critical in autistic spectrum disorders. One of the most promising discoveries has been the finding that the majority of individuals on the autistic spectrum are deficient in cholesterol and have abnormal amounts of cholesterol transport proteins. A recent article indicates that cholesterol supplementation should be considered in all cases of autistic spectrum disorder. Treatment of severe deficiency has lead to reductions of infections, improvements in sleep, social interactions, and growth. Behavior improvements include reduction in self-hurtful behavior, temper tantrums, aggressive behavior, and hyperactivity. Cholesterol is a critical factor in myelin production needed for brain growth and development, a cofactor in the brain development protein sonic hedgehog, a precursor of all steroid hormones and bile salts, and a critical factor in the function of serotonin and oxytocin receptors. Oxytocin, a hormone that stimulates social interaction and trust, has been found to be low in the blood of children with autism. Supplementation of oxytocin reduces autistic behaviors; combining cholesterol and oxytocin may be an especially effective treatment.
Uploaded 2 Plays0 Likes0 Comments
Why does the economically backward country of Cuba have an autism rate 100 times lower than the “advanced” United States? Why did the rate of autism soar in the early 1980s in the United States but not in Cuba? Could there be a single factor causing autism that is very common in the United States but is almost completely missing in Cuba?
During this webinar, Dr. Shaw will demonstrate how most of the biochemical abnormalities in autism can be tied to one single factor. This is brand new information that has never been presented before.